Mesut Eren

Title: Mesut Eren and His Patent on PAI-1 Inhibitor Screening

Introduction

Mesut Eren is an inventor associated with Vanderbilt University in Nashville, Tennessee. His patent work concerns methods and tools for evaluating candidate inhibitors of plasminogen activator inhibitor-1 (PAI-1), a protein involved in biological processes.

Latest Patents

Eren is associated with 1 patent, titled “Therapeutic Methods Employing PAI-1 Inhibitors and Transgenic Non-Human Animal for Screening Candidate PAI-1 Inhibitors.” The patent describes a method for testing whether a candidate composition inhibits PAI-1. It uses a transgenic, non-human warm-blooded vertebrate animal whose genome contains enough copies of a PAI-1 gene to produce overexpression of biologically active PAI-1. After the candidate composition is administered, the animal is observed for changes that may indicate inhibition of PAI-1 activity. The disclosure also covers a transgenic animal and a PAI-1 transgene construct intended for use in this screening approach.

Career Highlights

Eren’s documented patent contribution focuses on an experimental platform for assessing potential PAI-1 inhibitors. The approach combines genetic engineering with observation of biological changes in a transgenic animal model.

Collaborations

The supplied information identifies Paul Declerck and Douglas E. Vaughan as Eren’s coworkers. The patent’s subject matter reflects research involving PAI-1 biology and the development of methods for screening candidate inhibitors.

Conclusion

Mesut Eren’s patent work at Vanderbilt University centers on a transgenic-animal method for evaluating candidate PAI-1 inhibitors, linking genetic engineering with therapeutic research.